Arkis BioSciences
Knoxville
About Arkis BioSciences
Arkis BioSciences develops, markets, and sells advanced catheters and minimally invasive instrumentation for neurosurgery. Arkis' proprietary catheters incorporate Endexo, intended to reduce catheter related complications, while the company's instrumentation is designed to be less invasive over a variety of neurosurgical procedures. Altogether, the company's portfolio enables healthcare practitioners the potential to reduce surgical trauma, shorten surgical duration, and reduce treatment complications.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $9.6M
- Funding stage: M&A
- Last round: Convertible Note (Feb 2019)
- Website: arkisbiosciences.com
- Phone: (844)247-5383
Industries & Categories
Biotechnology, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/arkis-biosciences-33012 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.